biostatistics & programming

Enabling data-driven decision-making through precision analytics.

ProPharma's Biostatistics & Programming Expertise

At ProPharma, our biostatistics and programming team supports our clients through the entire product development journey and excels in transforming complex data into clear, actionable insights. Our global team ensures around-the-clock support and employs the latest industry standards, actively contributing to organizations like CDISC. We offer a comprehensive suite of services, from clinical study design and regulatory strategy support to clinical study execution, and provide real-time insights into what is happening with your data.

Utilizing advanced tools and languages like SAS, R, and Python, our team ensures high-quality, validated results. Our proven track record includes the successful completion of 10 NDA/BLA submissions in the past three years, demonstrating our commitment to excellence and regulatory compliance across a broad spectrum of therapeutic areas.

Person holding stethoscope and mobile phone in front of laptop
Medical device icon

Clinical Study Design

Clinical Study Design

Submissions icon

Regulatory Strategy

Regulatory Strategy

Full Service Clinical Trials icon

Clinical Study Execution

Clinical Study Execution

Spinning cog icon

Additional Services

Additional Services

Decentralized Clinical Trials icon

Therapeutic Areas

Therapeutic Areas

Clinical Study Design Services

  • Endpoint Selection
  • Analysis Method Determination
  • Sample Size Calculations/Statistical Power (simulations, adaptive design, etc.)
  • Type 1 Error Rate Adjustments 
  • Adaptive Design 
  • Protocol Development (writing and QC) 
Health care worker showing patient something on mobile phone

Regulatory Strategy Support

  • General Statistical Guidance/Recommendation
  • Clinical Program Design and Development 
  • FDA Meeting Prep, Attendance, and Follow-up
  • FDA Submission (NDA, BLA, etc.) Strategy, Attendance (Representation), Advisory Committee Support, Ad-Hoc Support, etc.
  • Integrated Summary of Safety and Efficacy (ISS/ISE) for NDA and BLA Submission Support
  • Study Data Standardization Plans (SDSP)
  • Global Regulatory Support for all regulatory agencies (EMA, MHRA, PMDA, etc.) 
Business worker sharing papers around a conference table

Clinical Study Execution Services

  • Randomization (Plan, Codes, List, etc.) 
  • eCRF Design and Review 
  • Blinding (Plan, Maintenance, etc.) 
  • Statistical Analysis Plan (SAP) 
  • Table, Listing, Figure Shells (TLFs)
  • CDISC Programming, Validation, and Associated Documentation (SEND, SDTM, ADaM) 
  • Statistical Analysis with Formal + Validated Reports (CSR Input and Review)
  • Pharmacokinetic and Pharmacodynamic Analyses 
Several business professionals having fun at a business meeting

Additional Services

  • Data Monitoring Committee (DMC) Services 
  • Health Economics and Outcomes Research (HEOR) 
  • Real World Evidence (RWE) 
  • Legacy CDSIC conversion data (SDTM and ADaM) 
  • Data Reconciliation 
  • Data Curation 
  • Data Visualization 
Data scientist reviewing data on a computer monitor

Therapeutic Areas Served

We can support statistical analysis and programming for a variety of therapeutic areas, including:

  • Cardiovascular
  • Dermatology
  • Endocrinology
  • Geriatrics
  • GI
  • Hematology
  • Immunology
  • Infectious Disease
  • Inflammatory diseases
  • Neurology
  • Oncology
  • Ophthalmology
  • Pain Management
  • Pediatrics
  • Rare Disease
  • Respiratory
  • Rheumatology
  • Urology
  • Vaccines
  • Women's Health
  • And more
Two lab workers working at computers in a lab

Comprehensive Biostatistics & Programming Support and Consulting

Message received icon

Clear Communication

We know that statistics and programming aren’t easily understood, and our team is here to help you know what’s going on with your data, in a way that makes sense and can be...

Read More

Clear Communication

We know that statistics and programming aren’t easily understood, and our team is here to help you know what’s going on with your data, in a way that makes sense and can be explained to those outside the biostatistics and programming realm.

Read Less
Partner icon

CDISC Volunteers

We ensure our clients benefit from the most current and compliant practices in the field. Our team members volunteer at CDISC to develop and refine industry standards.

CDISC Volunteers

We ensure our clients benefit from the most current and compliant practices in the field. Our team members volunteer at CDISC to develop and refine industry standards.

Read Less
Document search icon

Experienced with Health Authorities

Our teams have vast experience communicating with regulatory agencies worldwide, including FDA, EMA, MHRA, PMDA, Health Canada, TGA, NMPA, and more. 

Experienced with Health Authorities

Our teams have vast experience communicating with regulatory agencies worldwide, including FDA, EMA, MHRA, PMDA, Health Canada, TGA, NMPA, and more. 

Read Less
Expert Witness icon

NDA & BLA Submission Experience

We have completed 10 NDA/BLA submissions in the last 3 years. 

NDA & BLA Submission Experience

We have completed 10 NDA/BLA submissions in the last 3 years. 

Read Less
Spinning cog icon

Global Team

Our team members are located in five countries across the globe, allowing us to work with our sponsors around the clock. 

Global Team

Our team members are located in five countries across the globe, allowing us to work with our sponsors around the clock. 

Read Less
Innovation icon

Flexible Approach

Our flexible approach allows us to support our clients in whatever model best suits their needs, whether that is full-service CRO, functional service provider (FSP), or ad-hoc...

Read More

Flexible Approach

Our flexible approach allows us to support our clients in whatever model best suits their needs, whether that is full-service CRO, functional service provider (FSP), or ad-hoc consulting. 

Read Less

Our Biostatistics & Programming Consulting and Services

At ProPharma, we redefine the landscape of biostatistics and programming by offering far more than mere statistical analysis. Our diverse team of experts delivers unparalleled support across the entire spectrum of the life sciences journey, ensuring that our clients benefit from a holistic and integrated approach. With best-in-class communication skills, we demystify complex statistical processes, ensuring they are accessible and transparent to all stakeholders. This approach facilitates informed decision-making at every level of engagement and fosters a collaborative environment where insights lead to innovation. 

Our global, highly experienced team operates across time zones, providing around-the-clock support to our sponsors. When combined with our robust processes and global infrastructure, we accelerate project timelines and enhance quality and consistency across deliverables, significantly mitigating risks and optimizing operational efficiencies. We are flexible to support our clients with an outsourcing model that best suits their needs, including full-service CRO, FSP, or ad-hoc consulting.

Woman typing on computer keyboard
Business and healthcare professionals smiling around charts

Our Infrastructure & Tools

Quality and safety are at the heart of everything we do, especially when working with sensitive clinical trial data. Our team completes all work using our GXP-validated SAS server, and data is moved into and out of our environment through SFTPs.

We have programmers who are fluent in SAS, R, and Python languages, enabling us to work on any data type and conduct any data analysis needed. Our experienced team uses ProPharma's proprietary data visualization tool that enables our sponsors to view their data in real-time and to create their own graphics and dashboards providing them with key insights into their clinical trials in real-time.

Complex Needs Require Custom Solutions

We ensure that your statistical analysis is valid, complete, supported by the data, and presented in a way that is easy to understand. If you need support for your study data, ProPharma's experienced biostatistics and programming team can help. 

Biostatistics & Programming Experts

  •   Bio Photo

  •   Bio Photo

  •   Bio Photo

Thumbnail Image for Biostatistics and Programming - More than Just Clinical Trials

News & Insights

WHO Issues Guidance on Antibiotic Pollution Control

December 19, 2024

WHO Issues Guidance on Antibiotic Pollution Control

WHO issues guidance to control antibiotic pollution from manufacturing, addressing environmental and global health impacts of antimicrobial resistance.

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

December 18, 2024

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

Explore FDA's recommendations on follow-up testing for Ames-positive drugs to support first-in-human clinical trials. Learn how to navigate FDA regulations and ensuring successful product development.

Navigating Market Access & Reimbursement Strategy for Medical Devices in Europe

December 17, 2024

Navigating Market Access & Reimbursement Strategy for Medical Devices in Europe

Explore the importance of market access and reimbursement strategies for medical devices and in vitro diagnostics (IVDs) in Europe. Learn how early planning and the new European HTAR can enhance the...

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

Previous Post Arrow Next Post Arrow
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Previous Award Arrow Next Award Arrow
WHO Issues Guidance on Antibiotic Pollution Control

December 19, 2024

WHO Issues Guidance on Antibiotic Pollution Control

WHO issues guidance to control antibiotic pollution from manufacturing, addressing environmental and global health impacts of antimicrobial resistance.

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

December 18, 2024

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

Explore FDA's recommendations on follow-up testing for Ames-positive drugs to support first-in-human clinical trials. Learn how to navigate FDA regulations and ensuring successful product development.

Navigating Market Access & Reimbursement Strategy for Medical Devices in Europe

December 17, 2024

Navigating Market Access & Reimbursement Strategy for Medical Devices in Europe

Explore the importance of market access and reimbursement strategies for medical devices and in vitro diagnostics (IVDs) in Europe. Learn how early planning and the new European HTAR can enhance the...

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow